Gernot Riedel

Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’

Behavioural Pharmacology May 6, 2026 Bart A. Ellenbroek, Gernot Riedel

The past two decades have seen a remarkable renaissance in research on psychedelic drugs and ketamine. Following decades of regulatory restriction that severely limited, especially clinical research, a growing body of evidence has shown that psychedelics such as lysergic acid diethylamide and psilocybin can have long-lasting beneficial effects for treatment-resistant depression, drug and...